How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?
BACKGROUND Public access to up-to-date information on infectious diseases and outbreaks has grown rapidly with the advent of artificial intelligence platforms. While this information can improve patient care and support research, the sheer volume of available data coupled with the challenge of identifying misinformatio...